HMGB1 and neoplasm: Regarding ESCC, it has been reported that HMGB1 was overexpressed in the tumor and plasma of ESCC patients, and high levels of HMGB1 in ESCC tissues were associated with tumor progression, poor prognosis [35, 36], and development of radioresistance [37, 38].